Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gout and Hyperuricemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01082640
What this trial is testing

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Who this might be right for
Renal Impairment
Takeda 96
Large-scale testing (Phase 3)Looking for participantsNCT05658575
What this trial is testing

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Who this might be right for
Acute Gout FlareGout AttackGout Flare+4 more
Olatec Therapeutics, Inc. 300
Large-scale testing (Phase 3)Study completedNCT05586971
What this trial is testing

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

Who this might be right for
GoutHyperuricemiaGout Flare+1 more
LG Chem 2,202
Not applicableStudy completedNCT00175006
What this trial is testing

Validation Study of Physical Measurement of Tophi

Who this might be right for
Gout
Takeda 13
Testing effectiveness (Phase 2)Study completedNCT01109121
What this trial is testing

Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

Who this might be right for
Moderate to Severe GoutHyperuricemia
Nuon Therapeutics, Inc. 112
Not applicableUnknownNCT01818505
What this trial is testing

The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome

Who this might be right for
Antiphospholipid SyndromeEndothelial DysfunctionHyperuricemia+2 more
National Taiwan University Hospital 210
Early research (Phase 1)Study completedNCT01361646
What this trial is testing

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Who this might be right for
HyperuricemiaGout
LG Life Sciences 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT05690204
What this trial is testing

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Who this might be right for
Gout
Shanton Pharma Pte. Ltd. 87
Testing effectiveness (Phase 2)Study completedNCT00985127
What this trial is testing

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Who this might be right for
Gout
BioCryst Pharmaceuticals 99
Early research (Phase 1)Study completedNCT03211403
What this trial is testing

Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level

Who this might be right for
GoutHyperuricemia
Atridia Pty Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01101035
What this trial is testing

Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

Who this might be right for
Cardiovascular Disease
Takeda 6,198
Testing effectiveness (Phase 2)UnknownNCT01519687
What this trial is testing

Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

Who this might be right for
HyperuricemiaGout
Pharmos 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07498647
What this trial is testing

Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Who this might be right for
Gout and Hyperuricemia
BioRay Pharmaceutical Co., Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT00080210
What this trial is testing

Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy

Who this might be right for
Gout
Savient Pharmaceuticals 40
Early research (Phase 1)Ended earlyNCT02187029
What this trial is testing

Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.

Who this might be right for
Gout
Pfizer 30
Early research (Phase 1)Study completedNCT02890966
What this trial is testing

Multiple Dose Study of SHR4640 in Healthy Subjects

Who this might be right for
Gout; Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT06501534
What this trial is testing

A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects

Who this might be right for
GoutHyperuricemia
Innovent Biologics (Suzhou) Co. Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT07362355
What this trial is testing

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Who this might be right for
Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 340
Post-approval studies (Phase 4)Study completedNCT02600780
What this trial is testing

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

Who this might be right for
Hyperuricemia
Getz Pharma 50
Testing effectiveness (Phase 2)Study completedNCT03185793
What this trial is testing

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

Who this might be right for
Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 198
Next Page